// App-Quantinova.ai

COVD-15 : COVIDNEUROONC: A UK MULTI-CENTRE, PROSPECTIVE COHORT STUDY OF THE IMPACT OF THE COVID-19 PANDEMIC ON THE NEURO-ONCOLOGY SERVICE

Researchers

Presenter

  • Daniel Fountain

Principal Investigators

  • Michael Poon

  • Georgios Solomou

  • Paul M Brennan

  • Yasir Chowdhury

  • Francesca Colombo

  • Tarek Elmoslemany

  • Frederick Ewbank

  • Paul Grundy

  • Md Tanvir Hasan

  • Molly Hilling

  • Peter Hutchinson

  • Konstantina Karabatsou

  • Angelos Kolias

  • Nathan McSorley

  • Christopher Millward

  • Isaac Phang

  • Puneet Plaha

  • Stephen Price

  • Ola Rominiyi

  • William Sage

  • Syed Shumon

  • Ines Silva

  • Stuart Smith

  • Surash Surash

  • Simon Thomson

  • Jun Yi Lau

  • Colin Watts

  • Michael Jenkinson

Medical Centers

  • Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust & University of Manchester, Salford, United Kingdom

  • Department of Neuroradiology, John Radcliffe Hospital, Oxford, UK

  • Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom

  • School of Life Sciences, Keele University, Staffordshire, United Kingdom

  • Edinburgh Cancer Research UK Centre, Edinburgh, United Kingdom

  • Department of Ophthalmology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust , Birmingham, United Kingdom

  • Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust & University of Manchester, Salford, United Kingdom

  • Department of Neurosurgery, The Walton Centre NHS Foundation Trust & University of Liverpool, Liverpool, United Kingdom

  • University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

  • Paediatrics, Royal London Hospital Barts Health NHS Trust, London,United Kingdom

  • Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom

  • Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom

  • Department of Rheumatology, Ninewells Hospital, Dundee, United Kingdom

  • Department of Renal Medicine, Lancashire Teaching Hospital NHS Foundation Trust, Preston, United Kingdom

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • Department of Neurosurgery, School of Medicine, Queen’s Medical Centre, University of Nottingham, Nottingham, United Kingdom

  • Department ofAnaeshesia, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom

  • Department of Anaesthesia,Leeds General Infirmary, Leeds, United Kingdom

  • University of Birmingham, Birmingham, United Kingdom

  • University of Liverpool, Liverpool, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A